Bernofarm

What Bernofarm does

Bernofarm is an Indonesian for-profit, privately held pharmaceutical and healthcare manufacturer headquartered in Surabaya, Indonesia. Founded in 1971, the company manufactures and supplies a broad range of pharmaceuticals, healthcare, and nutraceuticals products on a nationwide basis within Indonesia. With 1,001-5,000 employees, Bernofarm operates at a mid-tier scale relative to larger Indonesian pharma groups, serving the domestic market through what appears to be a multi-channel distribution model spanning prescription pharmaceuticals, OTC healthcare products, and consumer nutraceuticals.

The company's product portfolio spans three adjacent but distinct categories — ethical pharmaceuticals, general healthcare products, and nutraceuticals — suggesting a diversified revenue base across regulatory classifications and consumer segments. As an Indonesian manufacturer operating in a regulated industry, Bernofarm is subject to BPOM licensing requirements and GMP manufacturing standards, which shape both its cost structure and competitive positioning. The company is privately held with no public ticker, no disclosed parent company, and no subsidiaries documented in the available data; its operating footprint is concentrated in Indonesia with no documented global expansion.

Business model mechanics are not disclosed in the available data: no pricing model, customer segmentation, channel structure, or revenue breakdown is publicly available, and the company website was inaccessible at the time of data collection (displaying only a loading/verification page). The most defensible characterization is that of a long-standing, mid-sized domestic Indonesian pharmaceutical and consumer health manufacturer operating across regulated and consumer health categories. Investors evaluating Bernofarm should treat revenue, customer mix, product-level economics, and growth trajectory as significant data gaps requiring primary research.

Name

Bernofarm

Website

https://bernofarm.com

Company type

Private

Founded year

1971

Headcount range

1,001–5,000 employees

Short description

Bernofarm is a privately held Indonesian pharmaceutical, healthcare, and nutraceuticals manufacturer founded in 1971 and headquartered in Surabaya, supplying products nationwide with 1,001-5,000 employees.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

akta.pro secondary industries

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Vitamins & Minerals (Single Nutrients) (CRADAGAB), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Pharmaceutical manufacturing
• Healthcare products
• Nutraceutical products
• Pharmaceutical distribution
• Generic medicines

Headquarters

HQ city

Surabaya

HQ country

Indonesia

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D

Core offering

Bernofarm manufactures and supplies a wide range of pharmaceutical, healthcare, and nutraceutical products distributed nationwide in Indonesia. The company produces finished dosage pharmaceutical products along with over-the-counter healthcare items and nutraceuticals for the domestic market. Its operations are headquartered in Surabaya and serve customers across the country.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical products

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Kimia Farma: State-owned Indonesian pharmaceutical manufacturer with integrated manufacturing, wholesale distribution, and retail pharmacy network. Highly comparable vertically integrated pharma manufacturer-distributor in the same domestic market.
• Kalbe Farma: Indonesia's largest listed pharmaceutical and consumer health company. Directly comparable as a domestic manufacturer-distributor of pharmaceuticals and nutraceuticals serving nationwide pharmacy, hospital, and modern trade channels.

Direct peers

• Tempo Scan Pacific: Listed Indonesian pharmaceutical and consumer products group manufacturing prescription drugs, OTC, and supplements. Comparable as a domestic manufacturer-distributor with overlapping product categories including nutraceuticals.
• Sanbe Farma: Indonesian pharmaceutical manufacturer with finished-dose generics, OTC, and nutraceutical offerings distributed nationwide. Comparable vertically integrated domestic pharma of similar scale.
• Mensa Group: Indonesian pharmaceutical manufacturer with prescription, OTC, and consumer health lines distributed through a nationwide network. Comparable domestic pharma manufacturer-distributor at similar scale tier.
• Indofarma: Indonesian state-owned pharmaceutical manufacturer producing finished generics and herbal/traditional medicines. Closely comparable as a domestic finished-dose pharma manufacturer distributing nationwide.
• Dexa Medica: Indonesian pharmaceutical manufacturer of branded generics and consumer health products. Comparable in scale, product mix (prescription + OTC + nutraceuticals), and nationwide distribution model.
• Pharos Indonesia: Indonesian pharmaceutical manufacturer-distributor with diversified prescription, OTC, and consumer health portfolio. Closely comparable mid-to-large domestic pharma with similar nationwide channel coverage.

Regional players

• Sido Muncul: Listed Indonesian herbal/traditional medicine and nutraceutical manufacturer with strong nationwide brand presence. Comparable in the nutraceutical and consumer health adjacencies of Bernofarm's portfolio.

Emerging players

• Combiphar: Indonesia-focused consumer healthcare and nutraceutical manufacturer with growing OTC and supplement portfolio. Comparable as a domestic player overlapping in the nutraceutical and OTC categories Bernofarm serves.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bernofarm